Clinical Trials Logo

Clinical Trial Summary

Gestational diabetes mellitus (GDM) is a high blood glucose (hyperglycemia) first occurring or first recognized during pregnancy, it is affecting 16.4% of women globally and 36.6 % in this region. It is consistent, strong evidence on the impact of GDM on short and long term health impacts on both mother and her child, thereby presenting significant challenges to acute care and public health. Currently, our understanding of strategies that are effective in preventing GDM is limited. Indeed, prospective studies have indicated a positive result of lifestyle intervention on preventing the risk of GDM in pregnant women but we lack consistency in the findings from randomized controlled trials (RCT). Moreover, most of these trials have been reported from developed countries and none of them were presented from this region. In the present project, we aim to determine whether GDM can be prevented by a 12-week moderate lifestyle intervention compared with usual standard care in high-risk pregnant women. In addition, we will also examine maternal pregnancy and birth outcomes.


Clinical Trial Description

Gestational diabetes mellitus (GDM) is a high blood glucose (hyperglycemia) first occurring or first recognized during pregnancy, it is affecting 16.4% of women globally and 36.6 % in this region. It is consistent, strong evidence on the impact of GDM on short and long term health impacts on both mother and her child, thereby presenting significant challenges to acute care and public health. Currently, our understanding of strategies that are effective in preventing GDM is limited. Indeed, prospective studies have indicated a positive result of lifestyle intervention on preventing the risk of GDM in pregnant women but we lack consistency in the findings from randomized controlled trials (RCT). Moreover, most of these trials have been reported from developed countries and none of them were presented from this region. In the present project, we aim to determine whether GDM can be prevented by a 12-week moderate lifestyle intervention compared with usual standard care in high-risk pregnant women. In addition, we will also examine maternal pregnancy and birth outcomes. If the results show a positive association, we could develop this as a clinical process for improving patient care and cost. This is a randomized controlled trial where participants will be included if they have more than one risk factors for GDM and randomized to two arms moderate-intensity lifestyle intervention (LI) or usual standard care group (control)(UC) between 6-12 gestational week. For the intervention group, standardized 12- week program and would be delivered in 4 sessions (2 individual, 2 telephonic) by a licensed dietitian. This lifestyle modification program is designed to achieve targeted weight gain and improve glycemic control through a combination of diet therapy, increased daily physical activity, and behavioral modification. The UC participants will receive no session as per the usual clinic protocol. Follow-up until l 24-28 gestational weeks, and the incidence of GDM was used to evaluate the effect of the intervention. At the end of interventions, participants in both arms will receive usual care based on their diagnosis and discretion of their physician. A sample size of 70 participants in each arm was estimated to give the power of 80%. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04273412
Study type Interventional
Source Rashid Centre for Diabetes and Research
Contact
Status Completed
Phase N/A
Start date October 13, 2018
Completion date July 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03067662 - Aerobic Exercise in Women With Gestational Diabetes N/A
Completed NCT05979519 - Fresh Carts for Mom's to Improve Food Security and Glucose Management N/A
Not yet recruiting NCT05951621 - The Patients With Gestational Diabetes Were Interfered With Qigong. N/A
Not yet recruiting NCT05003154 - Digitalized Management Exploration for Gestational Diabetes Mellitus in China N/A
Completed NCT05512871 - A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM) N/A
Completed NCT04054843 - Afamin in Gestational Diabetes Mellitus
Completed NCT04101396 - 4 vs 7 Points Blood Glucose Monitoring in Gestational Diabetes on Dietary Modification N/A
Not yet recruiting NCT05388643 - Early Detection of Gestational Diabetes Mellitus in Pregnancy N/A
Active, not recruiting NCT04948112 - Effectiveness of CGMS vs. Self-monitoring Blood Glucose (SMBG) in Woman With Gestational Diabetes N/A
Recruiting NCT04550806 - Glycated Albumin Combined With Body Composition for Gestational Diabetes Mellitus Prediction
Completed NCT05611541 - The Effect of Model-Based PMR Training on Anxiety and Blood Sugar Levels to Women With Gestational Diabetes N/A
Completed NCT03266133 - Sleep Intervention to Improve Glycemic Control in Women With Gestational Diabetes N/A
Active, not recruiting NCT05344066 - Manchester Intermittent Diet in Gestational Diabetes Acceptability Study N/A
Completed NCT03922087 - No-worry Baby Project
Recruiting NCT06099509 - Self-Administered 2-Hour Oral Glucose Tolerance Test N/A
Completed NCT02979756 - Improve Detection and Management of Gestational Diabetes Through the Primary Health Care Level in Morocco N/A
Not yet recruiting NCT05613920 - Dietary Management of Gestational Diabetes Mellitus N/A
Not yet recruiting NCT06005987 - Mobile App Logging for Diabetes in Pregnancy N/A
Completed NCT05067075 - The CGMS in GDM Labor and Delivery Study N/A
Active, not recruiting NCT05487352 - Diagnostic Analysis of Oral Glucose Tolerance Test in Early Pregnancy for Gestational Diabetes Mellitus